Primary Care Update 2023: Type 2 Diabetes, Metabolic Syndrome, and Obesity

Primary Care Update 2023: Type 2 Diabetes, Metabolic Syndrome, and Obesity is organized by Continuing Education, Inc. and will be held from Jun 04 - 11, 2023 at Holland America's Westerdam, Seattle, Washington, United States of America.

Program Purpose:
According to the most recent findings from the National Health and Nutrition Examination Survey (NHANES III), in the year 2011-2012, close to 70% of adult Americans were either overweight (with a body mass index of more than 25 kg/m2) or obese (with a BMI of more than 30 kg/m2).

Obesity is recognized as a multifactorial, chronic, inflammatory disease. This excess body fat is collected due to complex interactions between the environment, genetic predisposition, human metabolism, and neuroendocrine and behavioral factors. Obesity is characterized by a longer duration of inflammation than other chronic diseases.

Most people who take part in weight-loss programs, whether medically managed or self-selected, need to be more successful in losing or keeping weight. Despite this, an estimated 55 percent of the population is engaged in weight-loss programs at any given time. Over 60% of people who successfully lose weight will have put back on all the weight they lost by the end of the first year after their first success. Only about 15% of adults get the recommended amount of physical activity each week, and over 65% lead a sedentary lifestyle. Improved short-term and long-term outcomes, including quality of life indicators, can be attained through the treatment of cardiovascular risk factors through the adoption of lifestyle and behavioral interventions, which serve as the foundation of this approach.

The vital modifiable components of obesity and overweight include hypertension, dyslipidemia, diabetes mellitus, metabolic syndrome, and inflammation. These complications are caused by being overweight or obese. According to the findings of numerous studies, an effective treatment plan for overweight individuals and those who are obese must incorporate not just long-term behavioral adjustments that are supported by consistent monitoring but also the simultaneous medical management of cardiovascular risk factors.

There is an effect on the clinical decisions, treatment techniques, and health outcomes of all healthcare practitioners, regardless of their clinical specialty, due to the growing prevalence of obesity and overweight in patients. As a result, the overarching purpose of the planning of this conference has been to give medical professionals the most recent findings from scientific clinical research that investigates the scope of the problem, the hereditary and environmental factors that contribute to it, the pathophysiology of obesity, and the difficulties that are associated with it. Throughout the conference, this comprehension will be implemented into the clinical context using up-to-date evidence-based treatment options for the practical management of obesity and its associated comorbidities.

Topics:
• Explore the prevalence of obesity as a chronic disease, the tendency toward related comorbidities, and how this affects one's health.
• The mechanisms that link metabolic dysregulation to excessive amounts of adipose tissue.
• Explain the connection between having excess fatty tissue and metabolic dysregulation.
• Affective problems that have been linked to insulin resistance and obesity.
• Determine the extent to which specific comorbidities associated with obesity, such as mental disorders, eating disorders, and sleep apnea, affect the management measures.
• Considerations for the present and the future in the field of pharmacotherapy for overweight and obesity.
• Evaluate new recommendations for using existing pharmacologic agents and the future development of medications for treating type 2 diabetes, obesity, and overweight individuals.
• The part that one's genetic makeup plays in the obesity crisis.
• Recognize the distinct role that genetics and the surrounding environment play in the development of obesity.
• The effectiveness of bariatric surgery and the treatment of people who have obesity-related medical conditions.
• Discuss the efficacy of bariatric surgical techniques in terms of their effect on the pathophysiology and the management of obesity and type 2 diabetes.
• Interventions and lifestyle changes focus on behavior and ways of living to control diabetes, obesity, and overweight individuals.
• Explore the intricate web of connections that exists between the rational treatment of obesity and factors such as food, physical activity, the gut microbiota, and the immune system of the body.